Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,793 | -35,265 | -31,285 | -22,569 | -11,101 |
| Depreciation Amortization | 1,752 | 7,012 | 5,272 | 3,555 | 1,787 |
| Accounts receivable | -488 | -531 | -4,139 | 1,085 | 904 |
| Other Working Capital | -5,286 | 334 | -1,510 | 1,433 | -739 |
| Other Operating Activity | 1,647 | 5,179 | 7,613 | 1,326 | 547 |
| Operating Cash Flow | $-10,168 | $-23,271 | $-24,049 | $-15,170 | $-8,602 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -81 | -259 | -173 | -125 | -74 |
| Purchase Sale Intangibles | -63 | -144 | -126 | -107 | -63 |
| Other Investing Activity | -63 | -144 | -126 | -107 | -63 |
| Investing Cash Flow | $-144 | $-403 | $-299 | $-232 | $-137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | 10,000 | 10,000 | N/A |
| Debt Repayment | -5 | -21 | -16 | -12 | -7 |
| Common Stock Issued | 17,569 | 7,817 | 5,497 | 313 | 313 |
| Other Financing Activity | -667 | -1,379 | -773 | -415 | -209 |
| Financing Cash Flow | $16,897 | $16,417 | $14,708 | $9,886 | $97 |
| Beginning Cash Position | 19,075 | 26,332 | 26,332 | 26,332 | 26,332 |
| End Cash Position | 25,660 | 19,075 | 16,692 | 20,816 | 17,690 |
| Net Cash Flow | $6,585 | $-7,257 | $-9,640 | $-5,516 | $-8,642 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,168 | -23,271 | -24,049 | -15,170 | -8,602 |
| Capital Expenditure | -81 | -259 | -173 | -125 | -74 |
| Free Cash Flow | -10,249 | -23,530 | -24,222 | -15,295 | -8,676 |